Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines

BACKGROUND: Anthracycline cardiotoxicity (AC) may manifest years after treatment (long-term cardiotoxicity). There is little data on the incidence and natural history of AC in the current context, with protocols including lower anthracycline doses. The present study prospectively evaluated the incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Caballero, Rebeca Mata, Antolín, José María Serrano, Hernández, Rosa María Jiménez, Calle, Pedro Talavera, Ruigómez, Alejandro Curcio, Arrojo, Silvia del Castillo, Abad, Catherine Graupner, Varela, Carmen Cristóbal, Martín, Joaquín Jesús Alonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007491/
https://www.ncbi.nlm.nih.gov/pubmed/32329038
http://dx.doi.org/10.5603/CJ.a2020.0062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007491/
https://www.ncbi.nlm.nih.gov/pubmed/32329038
http://dx.doi.org/10.5603/CJ.a2020.0062

Ejemplares similares